SPARC (Support of Personalised Medicine Approaches in Cancer) is a 3-year project that was officially launched on 20-21 November in Madrid. 17 partners from 8 different countries will be collaborating for the next 3 years to advance equitable and sustainable personalised cancer medicine across Europe.
With a mission to ensure that the perspectives of patients, public, carers, healthcare professionals and other stakeholders are meaningfully involved into SPARC’s design, implementation and outcomes, Lungs Europe will be leading Work Package 7 on Patient, Citizens and Stakeholder Engagement.
More specifically, Lung Europe will be embedding patient and stakeholder perspectives into research and implementation, with a particular focus on patients and carers affected by cancers such as lung, breast, colorectal, prostate, melanoma, and rare forms of cancer.
Read the official press release here
